Case number 1:17-cv-00672
Allergan Sales LLC et al v. Macleods Pharmaceuticals, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 1 | Complaint (9) |
| Jul 20, 2018 | 40 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Numbers 8,039,009 B2 ;8,168,209 B2 ;8,173,708 B2 ;8,283,379 B2. (etg) |
| Apr 5, 2018 | 39 | Order (1) Docket Text: ORDER re [38] Stipulation of Dismissal filed by Allergan Sales, LLC, Adamas Pharma, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 4/5/18. (ntl) |
| Apr 3, 2018 | 38 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal Without Prejudice Pursuant to Fed. R. Civ. P. 41(A)(2) by Adamas Pharma, LLC, Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd.. (Blumenfeld, Jack) |
| Mar 29, 2018 | 37 | Redacted Document (1) Docket Text: REDACTED VERSION of [36] Letter by Adamas Pharma, LLC, Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd.. (Blumenfeld, Jack) |
| Mar 28, 2018 | 35 | Redacted Document (1) Docket Text: REDACTED VERSION of [33] Letter by Adamas Pharma, LLC, Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd.. (Blumenfeld, Jack) |
| Mar 28, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [34] STIPULATION TO EXTEND TIME to produce core technical documents to April 5, 2018 filed by Macleods Pharmaceuticals, Ltd., Macleods Pharma USA, Inc. Signed by Judge Leonard P. Stark on 3/28/18. (ntl) |
| Mar 26, 2018 | 34 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to produce core technical documents to April 5, 2018 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Stamoulis, Stamatios) |
| Mar 9, 2018 | 32 | Redacted Document (1) Docket Text: REDACTED VERSION of [31] Letter by Adamas Pharma, LLC, Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd.. (Noreika, Maryellen) |
| Feb 26, 2018 | N/A | SO ORDERED (0) |
| Feb 23, 2018 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Disclosures Pursuant to District of Delaware Default Standard Paragraph 3 filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd..(Stamoulis, Stamatios) |
| Feb 23, 2018 | 29 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and (2) Plaintiffs' Paragraph 4(a) Disclosures filed by Adamas Pharma, LLC, Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd..(Noreika, Maryellen) |
| Feb 22, 2018 | 28 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to (1) submit the interim status report; (2) exchange their preliminary claim terms and constructions; (3) submit their joint claim construction chart; and (4) submit their initial briefs on claim construction issues and tutorial to (1) March 8, 2018; (2) March 15, 2018; (3) March 22, 2018; and (4) April 2, 2018 - filed by Adamas Pharma, LLC, Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd.. (Blumenfeld, Jack) |
| Feb 20, 2018 | N/A | SO ORDERED (0) |
| Feb 16, 2018 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd..(Stamoulis, Stamatios) |
| Feb 15, 2018 | 26 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to (1) submit the interim status report and (2) exchange their preliminary claims terms and constructions to (1) February 22, 2018 and (2) March 1, 2018 - filed by Adamas Pharma, LLC, Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd.. (Blumenfeld, Jack) |
| Feb 9, 2018 | N/A | SO ORDERED (0) |
| Feb 8, 2018 | 25 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Adamas Pharmaceuticals, Inc. for Adamas Pharma, LLC; Corporate Parent Allergan plc for Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd. filed by Adamas Pharma, LLC, Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd.. (Noreika, Maryellen) |
| Feb 7, 2018 | N/A | SO ORDERED (0) |
| Feb 7, 2018 | 24 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Deadlines to February 15, 2018 - filed by Adamas Pharma, LLC, Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd.. (Noreika, Maryellen) |
| Feb 5, 2018 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Adamas Pharma, LLC, Allergan Sales, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC.(Noreika, Maryellen) |
| Feb 2, 2018 | 22 | Stipulation (2) Docket Text: STIPULATION to Substutute Party (Allergan Sales, LLC for Forest Laboratories, LLC) by Adamas Pharma, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC, Allergan Sales, LLC. (Noreika, Maryellen) |
| Feb 1, 2018 | N/A | SO ORDERED (0) |
| Jan 30, 2018 | 21 | Proposed Order (30) Docket Text: PROPOSED ORDER -- Stipulated Protective Order -- by Adamas Pharma, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. (Blumenfeld, Jack) |
| Jan 30, 2018 | N/A | Order Setting Mediation Conferences (0) Docket Text: ORAL ORDER Resetting Mediation Conference: At the request of counsel, the ADR Telephone Conference set for March 12, 2018 is rescheduled for 3/26/2018 at 11:45 AM before Judge Christopher J. Burke. Ordered by Judge Christopher J. Burke on 1/30/2018. (dlb) |
| Jan 26, 2018 | 20 | Order Setting Mediation Conferences (5) Docket Text: ORDER Setting Mediation Conference: A Telephone Conference is set for 3/12/2018 at 10:00 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 1/26/2018. (dlb) |
| Jan 24, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (dlb) |
| Jan 24, 2018 | 19 | Scheduling Order (15) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case Nos. 17-672 and 17-673 are CONSOLIDATED for all purposes and all papers shall be filed in 16-672. Discovery due by 6/21/2018. Status Reports due by 2/8/2018 and 6/14/18. Claim Construction Opening Brief due by 3/22/2018. Claim Construction Answering Brief due by 4/19/2018. A Markman Hearing is set for 5/7/2018 at 01:00 PM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 4/29/2019. A Final Pretrial Conference is set for 5/10/2019 at 11:30 AM in Courtroom 6B before Judge Leonard P. Stark. A 5-day Bench Trial is set for 5/20/2019 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 1/24/18. (ntl) |
| Jan 17, 2018 | 18 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of objections and responses to discovery filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd..(Stamoulis, Stamatios) |
| Dec 13, 2017 | 17 | Proposed Order (15) |
| Dec 13, 2017 | 17 | Letter to The Honorable Leonard P. Stark from M. Noreika enclosing order (1) |
| Dec 13, 2017 | 17 | Main Document (15) Docket Text: PROPOSED ORDER -- Scheduling Order -- by Adamas Pharma, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. (Attachments: # (1) Letter to The Honorable Leonard P. Stark from M. Noreika enclosing order)(Noreika, Maryellen) |
| Nov 29, 2017 | N/A | Order (0) |
| Nov 13, 2017 | N/A | SO ORDERED (0) |
| Nov 10, 2017 | 15 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Anne S. Toker - filed by Adamas Pharma, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. (Blumenfeld, Jack) |
| Oct 11, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Erin R. Conway for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-00672-LPS, 1:17-cv-00673-LPS(ceg) |
| Sep 27, 2017 | 14 | Answer to Counterclaim (14) Docket Text: ANSWER to [13] Answer to Complaint, Counterclaim by Adamas Pharma, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC.(Noreika, Maryellen) |
| Sep 6, 2017 | 13 | Answer to Complaint (27) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against All Plaintiffs by Macleods Pharmaceuticals, Ltd., Macleods Pharma USA, Inc..(Stamoulis, Stamatios) |
| Aug 22, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 11, 2017 | N/A | SO ORDERED (0) |
| Aug 9, 2017 | 12 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Joseph E. Cwik, and Erin R. Conway - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd.. (Stamoulis, Stamatios) |
| Aug 8, 2017 | N/A | SO ORDERED (0) |
| Aug 1, 2017 | 11 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Macleods to File Answer to September 6, 2017 - filed by Adamas Pharma, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. (Noreika, Maryellen) |
| Jun 29, 2017 | N/A | SO ORDERED (0) |
| Jun 28, 2017 | 10 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Robert B. Wilson, and Krista M. Rycroft - filed by Adamas Pharma, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. (Noreika, Maryellen) |
| Jun 8, 2017 | 8 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Macleods Pharma USA, Inc. on June 7, 2017 by Adamas Pharma, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. Waiver of Service due by 7/7/2017. (Noreika, Maryellen) |
| Jun 8, 2017 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Adamas Pharma, LLC: For Macleods Pharmaceuticals, Ltd. waiver sent on 6/7/2017, answer due 8/7/2017. (Noreika, Maryellen) |
| Jun 8, 2017 | 6 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Macleods Pharmaceuticals, Ltd. on June 7, 2017 by Adamas Pharma, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. Waiver of Service due by 7/7/2017. (Noreika, Maryellen) |
| Jun 8, 2017 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Adamas Pharma, LLC: For Macleods Pharma USA, Inc. waiver sent on 6/7/2017, answer due 8/7/2017. (Noreika, Maryellen) |
| Jun 7, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:17-cv-00672-LPS, 1:17-cv-00673-LPS (rjb) |
| Jun 5, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Macleods Pharma USA, Inc. on 6/5/2017; Macleods Pharmaceuticals, Ltd. on 6/5/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs) |
| Jun 2, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Adamas Pharmaceuticals, Inc. for Adamas Pharma, LLC; Corporate Parent Allergan plc. for Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC filed by Adamas Pharma, LLC, Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. (jcs) |
| Jun 2, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,039,009 B2; 8,168,209 B2; 8,173,708 B2; 8,283,379 B2. (jcs) |
| Jun 2, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/21/2017. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 10/21/2019. (jcs) |
| Jun 2, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) |
| Jun 2, 2017 | 1 | Civil Cover Sheet (1) |
| Jun 2, 2017 | 1 | Exhibit A-D (123) |
| Jun 2, 2017 | 1 | Main Document (9) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Macleods Pharma USA, Inc., Macleods Pharmaceuticals, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2154485.) - filed by Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Adamas Pharma, LLC. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(jcs) |
| Jun 2, 2017 | 1 | Complaint* (1) |
